Plain Language Summaries
Cross-source consensus on Plain Language Summaries from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Benefits
Dosage & preparation
Other
Highlighted claims
- Plain language summaries should be understandable, jargon-free, unbiased, non-promotional, accessible, and peer reviewed. — An Open Pharma Vision for company-sponsored biomedical research publications
- All peer-reviewed company research publications should include plain language summaries. — An Open Pharma Vision for company-sponsored biomedical research publications
- The immediate priority is to include plain language summaries in publications underpinning regulatory drug or medical device approvals. — An Open Pharma Vision for company-sponsored biomedical research publications
- Plain language summaries are framed as necessary because many groups influence health outcomes and need understandable research. — An Open Pharma Vision for company-sponsored biomedical research publications
- A text-based plain language summary of about 250 words within the peer-reviewed publication is endorsed as a minimum. — An Open Pharma Vision for company-sponsored biomedical research publications
- Plain language summaries are expected to improve transparency, accountability, accessibility, discoverability, understandability, and equity in medical research. — An Open Pharma Vision for company-sponsored biomedical research publications